Biophytis (EPA:ALBPS) | Finanzwire

Basculer en Français

11034	Companies
241788	Keywords
170214	Articles
130158	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 07/08/2025 at 07:00, 1 year 2 months ago

Biophytis at the Forefront of Longevity Innovation at the World Aging & Rejuvenation Conference 2025
Biophytis SA announces participation in ARC 2025 to present results of BIO101 in sarcopenia at the World Aging & Rejuvenation Conference, aiming to strengthen scientific visibility and expand in the longevity market

Sarcopenia Biophytis SA BIO101 Longevity Market ARC 2025
BRIEF

published on 07/07/2025 at 07:05, 1 year 2 months ago

Biophytis Aims to Address Muscle Loss in Obesity Market

Biophytis BIO101 Muscle Preservation GLP-1 Therapies Obesity Market
REGULATED PRESS RELEASE

published on 07/07/2025 at 07:00, 1 year 2 months ago

Obesity: Biophytis Charts Its Course Toward a Booming Market
Biophy.s SA is focusing on developing transformative therapies for obesity, sarcopenia, and longevity by addressing muscle loss with its lead drug BIO101. The company's strategic positioning targets the expanding obesity market

BIO101 Obesity Market Opportunity Muscle Loss Biophy.s SA
BRIEF

published on 07/03/2025 at 07:05, 1 year 2 months ago

Biophytis Showcases Innovations at BIO International 2025

Biophytis Precision Medicine Longevity Sarcopenia Obesity Therapy
REGULATED PRESS RELEASE

published on 07/03/2025 at 07:00, 1 year 2 months ago

Biophythis Powers Innovation in Obesity, Muscle Health, and Longevity at BIO International 2025
Biophytis highlights innovations in obesity, muscle health, and longevity at BIO International 2025, showcasing therapies targeting key health challenges. Strategic partnerships post-conference aim to accelerate therapies' global impact

Innovations Longevity Obesity Muscle Health Biophy(s
BRIEF

published on 06/30/2025 at 22:35, 1 year 2 months ago

Biophytis Delays Publication of 2024 Annual Financial Statements

Biophytis Biotechnology Drug Development Annual Accounts Financial Delay
REGULATED PRESS RELEASE

published on 06/30/2025 at 22:30, 1 year 2 months ago

Information on the Annual Financial Statements
Biophytis delays publishing of 2024 annual accounts, aiming for release by July 7. The company focuses on treatments for age-related diseases

Financial Statements Biophytis Age-related Diseases 2024 Annual Accounts Clinical-stage Biotechnology Company
PRESS RELEASE

published on 06/30/2025 at 22:29, 1 year 2 months ago

Information on the Annual Financial Statements
Biophytis SA delays publication of 2024 annual accounts, aiming to release by July 7. The clinical-stage biotech company focuses on age-related disease treatments

Biotechnology Company Clinical-stage Biophytis SA Age-related Diseases 2024 Annual Accounts
BRIEF

published on 06/19/2025 at 23:05, 1 year 3 months ago

Biophytis Temporarily Suspends Share Trading

Biophytis Regulatory Compliance Financial Report Euronext Growth Share Suspension
REGULATED PRESS RELEASE

published on 06/19/2025 at 23:00, 1 year 3 months ago

Biophytis announces the temporary suspension of the trading of its shares
Biophytis announces temporary suspension of trading shares on Euronext due to delayed financial report. Expected to resume after report publication. Company info included

Biophytis Euronext Trading Financial Report Suspension

Accesswire

Published on 09/19/2026 at 00:55, 2 days 9 hours ago

Gossan Resources Announces Changes to Board and Management
Published on 09/18/2026 at 23:50, 2 days 10 hours ago

Mako Mining Announces Equity Incentive Grants
Published on 09/18/2026 at 22:00, 2 days 12 hours ago

Silver Tiger Announces Results of Annual and Special Meeting
Published on 09/18/2026 at 20:35, 2 days 13 hours ago

Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years
Published on 09/18/2026 at 14:30, 2 days 19 hours ago

AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement

View all ACCESSWIRE

EQS Group

Published on 09/21/2026 at 10:07, 9 minutes ago

POS-Transaction in Own Shares
Published on 09/21/2026 at 10:05, 11 minutes ago

NETMARBLE WRAPS UP TOKYO GAME SHOW 2026 WITH THREE UPCOMING TITLES
Published on 09/21/2026 at 10:00, 17 minutes ago

ams OSRAM unveils breakthrough Thin-Film VCSEL for AI Scale-Up, showcasing connectorized multi-core fiber solution and expanding ecosystem network
Published on 09/21/2026 at 09:40, 37 minutes ago

EQS-Adhoc: Deutsche Bank to issue Additional Tier 1 capital instruments
Published on 09/21/2026 at 09:35, 41 minutes ago

Circus SE: CEO Nikolas Bullwinkel to Speak at Goldman Sachs and Bank of America Stages – Keynotes at Further Investor Conferences

Les Echos

Published on 09/21/2026 at 07:00, 3 hours 17 minutes ago

Peugeot Invest takes a stake in Mérieux NutriSciences
Published on 09/18/2026 at 18:34, 2 days 15 hours ago

Disclosure of transactions in own shares from September 14 to September 18, 2026
Published on 09/18/2026 at 17:45, 2 days 16 hours ago

Press Release_Carrefour Bond_September 2026
Published on 09/18/2026 at 17:45, 2 days 16 hours ago

Share buyback for cancellation
Published on 09/17/2026 at 17:40, 3 days 16 hours ago

Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany

View all LES ECHOS COMFI WIRE